From left: Konstantinos Meletis, Antje Märtin, Daniela Calvigioni and Rania...
From left: Konstantinos Meletis, Antje Märtin, Daniela Calvigioni and Rania Tzortzi, researchers at the Department of Neuroscience at Karolinska Institutet.

Photo: Juan Perez Fernandez.

News • Molecular map

Striatum: where our brain makes decisions

Researchers at Karolinska Institutet have come one step closer toward understanding how the part of our brain that is central for decision-making and the development of addiction is organized on a molecular level.

In mouse models and with methods used for mapping cell types and brain tissue, the researchers were able to visualize the organization of different opioid-islands in striatum. Their spatiomolecular map, which has now been published in the journal Cell Reports, may further our understanding of the brain’s reward-system.

Striatum is the inner part of the brain that among other things regulates rewards, motivation, impulses and motor function. It is considered central to decision-making and the development of various addictions.

In this study, the researchers created a molecular 3D-map of the nerve cells targeted by opioids, such as morphine and heroin, and showed how they are organized in striatum. It is an important step toward understanding how the brain’s network governing motivation and drug addiction is organized. In the study, the researchers described a spatiomolecular code that can be used to divide striatum into different subregions.

Recommended article

Photo

Article • Brain MRI-mining

The birth of psychoradiology

The emerging field of psychoradiology is taking a major step ahead. A new study highlights MRI’s role in identifying people with attention deficit and hyperactivity disorder (ADHD) and classifies subtypes of the condition, a leading Chinese researcher explained at the ESMRMB annual meeting.

This is the first step in directly defining the networks’ role in controlling decision-making and addiction with the help of optogenetics

Konstantinos Meletis

“Our map forms the basis for a new understanding of the brain’s probably most important network for decision-making,” says Konstantinos Meletis, associate professor at the Department of Neuroscience at Karolinska Institutet and the study’s main author. “It may contribute to an increased understanding of both normal reward processes and the effects of various addictive substances on this network.”

To find this molecular code, the researchers used single-nucleus RNA sequencing, a method to study small differences in individual cells, and mapping of the striatal gene expression. The results provide the first demonstration of molecular codes that divide the striatum into three main levels of classification: a spatial, a patch-matrix and a cell-type specific organization. “With this new knowledge we may now begin to analyze the function of different types of nerve cells in different molecularly defined areas,” says Meletis. “This is the first step in directly defining the networks’ role in controlling decision-making and addiction with the help of optogenetics.”

This new knowledge may also form the basis for the development of new treatments based on a mechanistic understanding of the brain’s network, according to the researchers.


Source: Karolinska Institutet

02.01.2020

Read all latest stories

Related articles

Photo

News • Molecular diversity

New insights into abnormal proteins in Parkinson’s disease and MSA

Parkinson’s and multisystem atrophy (MSA) – both of them neurodegenerative diseases – are associated with the accumulation of alpha-synuclein proteins in the brain. Researchers at the German…

Photo

News • Rare but potentially serious complication

First cases of encephalomyelitis resulting from monkeypox virus

As the monkeypox outbreak continues to spread around the globe, a rare but potentially serious complication of the virus has been discovered.

Photo

News • Blood-brain barrier simulation

Artificial brain vessels advance drug testing

German researchers present a novel method for testing chemical agents that could help in the development of drugs against neurodegenerative diseases such as Alzheimer's.

Related products

Sarstedt – Low DNA Binding Micro Tubes

Research Use Only

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Sense Biodetection, Ltd. - Veros Covid-19

Other

Sense Biodetection, Ltd. - Veros Covid-19

Sense Biodetection, Ltd.
Shimadzu – CLAM-2030 CL (IVD)/ CLAM-2030 (RUO)

Mass Spectrometry

Shimadzu – CLAM-2030 CL (IVD)/ CLAM-2030 (RUO)

Shimadzu Europa GmbH
Shimadzu – LCMS-8060NX CL (IVD) / LCMS-8060 NX (RUO)

Mass Spectrometry

Shimadzu – LCMS-8060NX CL (IVD) / LCMS-8060 NX (RUO)

Shimadzu Europa GmbH
Shimadzu – MALDImini-1

Research Use Only

Shimadzu – MALDImini-1

Shimadzu Europa GmbH
Subscribe to Newsletter